Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513

NCT03507569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: RO7017773
OTHER: [11C] Ro15-4513

Sponsor

Hoffmann-La Roche